Pharmaron Holdings Ltd - CA Orange, Irvine 92618

Pharmaron Holdings Ltd entered the industry of Biological Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417110, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Boliang Lou, Chief Executive Officer by calling (949) 788-0586 during business hours. You can also write to the business’ Single Location at 6 Venture # 250, Irvine, California CA 92618. You can also visit the company’s website at pharmaron.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Pharmaron Holdings Ltd
Representative: Boliang Lou, Chief Executive Officer
Place of Business: 6 Venture # 250, Irvine, CA 92618
Contact Number: (949) 788-0586
Website: pharmaron.com
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 5417110
Locality: Single Location
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Pharmaron Holdings Ltd is a company operating from Orange, California providing professional Biological Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 5417110 as Biological Research.

With a current employee count of 1 to 4, Pharmaron Holdings Ltd has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Boliang Lou, Chief Executive Officer at (949) 788-0586 for related queries, or to locate its Single Location using the coordinates 33.659742,-117.752377.

The Single Location can also be found at the street address 6 Venture # 250 in Irvine, California 92618 and can be engaged online through the company website at pharmaron.com, the company Twitter , and Facebook page .